Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03971461
Title Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NYU Langone Health
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
NYU Langone Health New York New York 10016 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field